Literature DB >> 6354903

Prognostic factors in cirrhosis identified by Cox's regression model.

P Schlichting, E Christensen, P K Andersen, L Fauerholdt, E Juhl, H Poulsen, N Tygstrup.   

Abstract

In a controlled clinical trial in 488 patients with chronic liver disease treated with prednisone or placebo, survival data were analyzed using Cox's proportional hazards model. A total of 162 variables were screened separately for prognostic and/or therapeutic effect by log-rank analyses, whereby 46 clinical, biochemical, serological, and histological variables were isolated. Another five variables traditionally found to be important in patients with liver disease were included. After extensively checking the assumptions of the model, the 51 variables were, by a step-wise procedure, reduced to a final model. It comprised, besides a treatment indicator, 12 variables with significant (p less than 0.05) prognostic or therapeutic effect. The following eight variables had a significant prognostic effect: sex, age, prothrombin, acetylcholinesterase, eosinophil leucocytes in liver parenchyma, liver cell necrosis, inflammation in liver connective tissue, and efferent veins in parenchymal nodules. A prognostic index based on the final model is formed allowing calculation of 5 years survival probability. The usefulness of the prognostic index was tested by a cross-validation method, and no statistical significant difference was found between the estimated and observed survivorship functions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6354903     DOI: 10.1002/hep.1840030601

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  25 in total

1.  The additive nonparametric and semiparametric Aalen model as the rate function for a counting process.

Authors:  Thomas H Scheike
Journal:  Lifetime Data Anal       Date:  2002-09       Impact factor: 1.588

2.  Prediction of the prognosis of liver cirrhosis in Japanese using Cox's proportional hazard model.

Authors:  Y Tsuji; S Koga; H Ibayashi; Y Nose; K Akazawa
Journal:  Gastroenterol Jpn       Date:  1987-10

3.  Regression analysis of restricted mean survival time based on pseudo-observations.

Authors:  Per Kragh Andersen; Mette Gerster Hansen; John P Klein
Journal:  Lifetime Data Anal       Date:  2004-12       Impact factor: 1.588

4.  Dynamic path analysis for event time data: large sample properties and inference.

Authors:  T Martinussen
Journal:  Lifetime Data Anal       Date:  2009-08-22       Impact factor: 1.588

5.  Contribution to the discussion of 'Survival models and health sequences' by W. Dempsey and P. McCullagh.

Authors:  Per Kragh Andersen
Journal:  Lifetime Data Anal       Date:  2018-07-18       Impact factor: 1.588

6.  Functional hepatic imaging with receptor-binding radiopharmaceutical: clinical potential as a measure of functioning hepatocyte mass.

Authors:  M Kudo; A Todo; K Ikekubo; M Hino; Y Yonekura; K Yamamoto; K Torizuka
Journal:  Gastroenterol Jpn       Date:  1991-12

7.  Natural history of major complications in hepatitis C virus-related cirrhosis evaluated by per-rectal portal scintigraphy.

Authors:  Etsushi Kawamura; Daiki Habu; Takehiro Hayashi; Ai Oe; Jin Kotani; Hirotaka Ishizu; Kenji Torii; Joji Kawabe; Wakaba Fukushima; Takashi Tanaka; Shuhei Nishiguchi; Susumu Shiomi
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

8.  Multivariate analyses of factors associated with unemployment in people with multiple sclerosis.

Authors:  M Grønning; E Hannisdal; S I Mellgren
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-05       Impact factor: 10.154

9.  Prognostic index of cirrhotic patients with hepatic encephalopathy with and without hepatocellular carcinoma.

Authors:  Keiichiro Yoneyama; Yuka Nebashi; Yuji Kiuchi; Minoru Shibata; Keiji Mitamura
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

10.  Factors influencing survival at one year in patients with nonbiliary hepatic parenchymal cirrhosis.

Authors:  M Adler; J Van Laethem; A Glibert; M Gelin; N Bourgeois; P Vereerstraeten; M Cremer
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.